Becton Dickinson (BDX)Director sold ~$174K
Bertram L Scott, Director at Becton Dickinson, sold ~$174K of Becton Dickinson shares.
- ~$174K
- Approx. value · 953 sh @ $182.61
- 37K
- Holds after · shares reported
- Traded
- Feb 18, 2026
- Filed
- Feb 18, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 9, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On October 15, 2025, the Company filed a Current Report on Form 8-K that reported that Vitor Roque, who previously served as the Company’s Senior Vice President of Finance, Business Units and Corporate Financial Planning & Analysis, was appointed as the Company’s interim Chief Financial Officer, effective December 5, 2025.”
- Dec 26, 2025InsiderOfficer sold ~$15K of BDX shares in the open market
- Dec 30, 2025Company filing · Form 8-K · Temporary Suspension of Trading Under Registrant's Employee Benefit PlansSuspended trading under its employee plans
- Jan 15, 2026Insider · 1 personInsiders: 2 sales (~$334K)
- Jan 26, 2026InsiderOfficer sold ~$15K of BDX shares in the open market
- Jan 27, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On January 27, 2026, the Board of Directors of Becton, Dickinson and Company (“BD”) approved and adopted the BD Executive Severance Plan (the “Severance Plan”), effective January 27, 2026.”
- Jan 30, 2026Company filing · Form 8-K · Unregistered shares, Bylaws or charterSold new shares without registering them, and changed its bylaws, charter or fiscal year
- Jan 30, 20265% stakeThe Vanguard Group reported a passive stake (13G) of 12.8%
- Feb 9, 2026Company filing · Form 8-K · ResultsReported its results
- Feb 9, 2026Company filing · Form 8-K · Material agreement, Executive changeChanged a top executive or board member, and signed an important agreement (and 2 more items)“In connection with the completion of the Transactions, and effective as of the Closing, Claire M. Fraser, Ph.D., resigned as a director of the Company and was appointed to the Waters board of directors.”
- Feb 18, 2026 · this disclosureInsiderDirector sold ~$174K of BDX shares in the open market
What came next
- Feb 26, 2026InsiderOfficer sold ~$14K of BDX shares in the open market
- Mar 17, 2026CongressDisclosed sale of BDX — reported range $15,001 - $50,000
- Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Mar 26, 2026InsiderOfficer sold ~$12K of BDX shares in the open market
- Apr 2, 2026Company filing · Form 8-K · ResultsReported its results
- Apr 6, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On April 6, 2026, Richard E. Byrd, Executive Vice President and President of the Interventional segment of Becton, Dickinson and Company (“BD”), informed BD of his intention to retire.”
- Apr 27, 2026InsiderOfficer sold ~$11K of BDX shares in the open market
- Apr 28, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
- Apr 29, 20265% stakeVanguard Portfolio Management reported a passive stake (13G) of 5.4%
- Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
- May 7, 2026Company filing · Form 8-K · ResultsReported its results
- May 15, 20265% stakeT. Rowe Price Investment Management, Inc. reported a passive stake (13G) of 3.4%
- May 20, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
- May 21, 2026CongressDisclosed sale of BDX — reported range $1,001 - $15,000
- May 26, 2026InsiderOfficer sold ~$11K of BDX shares in the open market
- May 28, 2026FDARecall: BD ChloraPrep Clear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA) 1 mL Applicator, 60 Applicators, Sterile Solution, Care Fusion 2…
- May 28, 2026FDARecall: BD ChloraPrep FREPP Clear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA) 1.5 mL Applicator, 20 Applicators, Sterile Solution, Care…
- May 28, 2026FDARecall: BD ChloraPrep Clear (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA)), 1 mL Applicator, 60 Applicators per inner Carton, Sterile Solut…
- May 28, 2026FDARecall: BD ChloraPrep FREPP Clear,(2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA)) 1.5 mL Applicator, 20 Applicators, Sterile Solution, Care…
- May 29, 2026FDAFDA device clearance: BD Touchless Plus Unisex Pre-Lubricated Urethral Catheter Kit
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Becton Dickinson
For Becton Dickinson, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 28 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BDX page.
Other recent filings by Bertram L Scott, Director
- SEC Form 4 at Equitable Holdings (EQH)Sep 21, 2026
- SEC Form 4 at Equitable Holdings (EQH)Aug 10, 2026
- SEC Form 4 at Equitable Holdings (EQH)Jun 5, 2026
- SEC Form 4 at Becton Dickinson (BDX)Nov 7, 2025
- SEC Form 4 at Equitable Holdings (EQH)Aug 22, 2025
The full history of Bertram L Scott, Director is on the profile page.
How this filing works
Other disclosures at Becton Dickinson
- SEC Form 4Sep 30, 2026
- SEC Form 144Sep 28, 2026
- SEC Form 4Aug 27, 2026
- SEC Form 13F-HRAug 18, 2026
- SEC Form 4Aug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its BDX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
